Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 13/1/2021
SIETES contiene 93213 citas

 
 
 1 a 20 de 23 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Coyne DW. Anemia in chronic kidney disease: treating the numbers, not the patients. JAMA Intern Med 2014;174:708-9. [Ref.ID 97192]
2.Tiene citas relacionadas Cita con resumen
Inrig JK, Barnhart HX, Reddan D, Patel UD, Sapp S, Califf RM, Singh AK, Szczech LA. Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial. Am J Kidney Dis 2012;60:390-41. [Ref.ID 92942]
3.Tiene citas relacionadas
Pfeffer MA, Eckardt K-U, Toto R. Darbepoetin alfa and chronic kidney disease. The authors reply. N Engl J Med 2010;362:655. [Ref.ID 87900]
4.Tiene citas relacionadas
Locatelli F, Del Vecchio L, Casartelli D. Darbepoetin alfa and chronic kidney disease. N Engl J Med 2010;362:654-5. [Ref.ID 87899]
5.Tiene citas relacionadas
Hampl H, Kovesdy CP, Kalantar-Zadeh K. Darbepoetin alfa and chronic kidney disease. N Engl J Med 2010;362:654. [Ref.ID 87898]
6.Tiene citas relacionadas
Schäbitz WR. Darbepoetin alfa and chronic kidney disease. N Engl J Med 2010;362:653-4. [Ref.ID 87897]
7.Tiene citas relacionadas
Wright RJ, Kanagasundaram NS, Quinton R. Darbepoetin alfa and chronic kidney disease. N Engl J Med 2010;362:653. [Ref.ID 87896]
8.Tiene citas relacionadas Cita con resumen
Unger EF, Thompson AM, Blank MJ, Temple R. Erythropoiesis-stimulating agents - Time for a reevaluation. N Engl J Med 2010;362:189-92. [Ref.ID 87577]
9.Tiene citas relacionadas
Marsden PA. Treatment of anemia in chronic kidney disease - Strategies based on evidence. N Engl J Med 2009;361:2089-90. [Ref.ID 87325]
10.Tiene citas relacionadas Cita con resumen
Pfeffer MA, Burdmann EA, Chen C-Y, Cooper ME, de Zeeuw D, Eckardt K-U, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJV, Parfrey P, Parving H-H, Remuzzi G, Singh AK, Solomon SD, Toto R, for the TREAT Investigators. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009;361:2019-32. [Ref.ID 87324]
11. Cita con resumen
Anónimo. Erythropoietin safety concerns. Med Lett Drugs Ther 2007;49:37-9. [Ref.ID 80161]
12.
Tonks A. Too much of a good thing. BMJ 2007;334:978-80. [Ref.ID 80091]
13.Tiene citas relacionadas
Pfeffer MA. An ongoing study of anemia correction in chronic kidney disease. N Engl J Med 2007;356:959-61. [Ref.ID 79391]
14.Tiene citas relacionadas
Drüeke TB, Eckardt KU, Scherhag A. Chronic kidney disease, anemia, and epoetin. Dr. Drüeke and colleagues reply. N Engl J Med 2007;356:959. [Ref.ID 79390]
15.Tiene citas relacionadas
Singh AK, Wolfson MR, Reddan D. Chronic kidney disease, anemia, and epoetin. Dr. Singh and colleagues reply. N Engl J Med 2007;356:958-9. [Ref.ID 79389]
16.Tiene citas relacionadas
Roger SD. Chronic kidney disease, anemia, and epoetin. N Engl J Med 2007;356:958. [Ref.ID 79388]
17.Tiene citas relacionadas
Ashrani AA, Rajkumar SV. Chronic kidney disease, anemia, and epoetin. N Engl J Med 2007;356:957-8. [Ref.ID 79387]
18.Tiene citas relacionadas
Go AS, Ayus JC. Chronic kidney disease, anemia, and epoetin. N Engl J Med 2007;356:957. [Ref.ID 79386]
19.Tiene citas relacionadas
Mikhail A, Goldsmith D. Chronic kidney disease, anemia, and epoetin. N Engl J Med 2007;356:956-7. [Ref.ID 79385]
20.Tiene citas relacionadas
Riley DS. Chronic kidney disease, anemia, and epoetin. N Engl J Med 2007;356:956. [Ref.ID 79384]
Seleccionar todas
 
 1 a 20 de 23 siguiente >>